Skip to content
Screener

Insulet PODD International — Total Revenue

Other product segments

Drug Delivery
$5.8M-43.1%

Similar metrics at other companies

DocuSign logo
DOCUInternational — Total Revenue
$253.91M+16.8%
Domo, Inc. logo
DOMOInternational — Total Revenue
$16.99M+7.9%
Gemini Space Station logo
GEMIInternational — Total Revenue
$5.1M+30.7%
Butterfly Network logo
BFLYInternational — Total Revenue
$5.02M-14.1%
iRadimed logo
IRMDInternational — Total Revenue
$3.95M+11.1%
Dolby Laboratories, Inc. logo
DLBInternational — Total Revenue
$175.58M-15.6%

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.23B-52.7%
Enterprise value$9.67B-52.3%
P/E24.6×-58.1×
P/S-5.2×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
U.S.$544.1$453.2$1,059.7$854.9
International251.8185.8494.6338.1
Total Omnipod products795.9639.01,554.31,193.0
Drug Delivery5.810.29.125.1
Total revenue$801.7$649.1$1,563.4$1,218.1

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's international — total revenue?
Insulet (PODD) reported international — total revenue of $251.8M in Q2 2026.
How has Insulet's international — total revenue changed year-over-year?
Insulet's international — total revenue increased by 35.5% year-over-year, from $185.8M to $251.8M.
What is the long-term trend for Insulet's international — total revenue?
Over 4 years (2021 to 2025), Insulet's international — total revenue has grown at a 20.3% compound annual growth rate (CAGR), from $359.9M to $754.3M.
What does international — total revenue mean?
This metric captures the aggregate revenue specifically attributed to the international distribution of the company's flagship insulin management platform. It serves as a key performance indicator for the adoption rate of the company's proprietary technology within global healthcare markets. By isolating this revenue stream, stakeholders can evaluate the specific demand for the product line in non-domestic markets.

Ask your AI about Insulet's international — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude